The proapoptotic BCL-2 family proteins BAX and BAK serve as essential gatekeepers of the intrinsic apoptotic pathway and, when activated, transform into pore-forming homo-oligomers that permeabilize the mitochondrial outer membrane. Deletion of Bax and Bak causes marked resistance to death stimuli in a variety of cell types. Bax À / À Bak À / À mice are predominantly non-viable and survivors exhibit multiple developmental abnormalities characterized by cellular excess, including accumulation of neural progenitor cells in the periventricular, hippocampal, cerebellar and olfactory bulb regions of the brain. To explore the long-term pathophysiological consequences of BAX/BAK deficiency in a stem cell niche, we generated Bak 
INTRODUCTION
Programmed cell death plays an essential role during development and homeostasis by eliminating superfluous or damaged cells. The pro-and antiapoptotic members of the BCL-2 family integrate internal and external stress stimuli to arrive at a life or death decision for the cell. 1 BAX and BAK are the two key executioner proteins of the mitochondrial apoptotic pathway. 2 When activated by persistent stress signaling, BAX and BAK transform from a monomeric state into homo-oligomers that pierce the mitochondrial outer membrane and release apoptogenic factors, which drive the caspase cascade. 3 Whereas cells and tissues deficient in BAX or BAK preserve apoptotic function due to apparent functional redundancy, double deficiency leads to profound apoptotic resistance. 4 Indeed, only mice deficient in both Bax and Bak are embryonic lethal and the minority that do survive exhibit cellular excess in discrete tissues. 4 Observed abnormalities in Bax À / À Bak À / À mice include (1) retention of interdigital webs, (2) failure to develop an external vaginal introitus, (3) lymphoid accumulation as reflected by leukocytosis, splenomegaly, lymphadenopathy and parenchymal infiltrates, and (4) neural progenitor cell hypercellularity within the SVZ, hippocampus, cerebellum and olfactory bulb. This constellation of developmental and homeostatic defects highlights the critical roles of BAX/BAK-mediated apoptosis in maintaining the functional integrity of cells and tissues.
Deregulation of the BCL-2 family interaction network has emerged as a contributing etiology for a host of human diseases characterized by either pathological cellular excess (for example, cancer) or cellular deficiency (for example, neurodegeneration). Overexpression of BCL-2 family antiapoptotic proteins is well known to drive the development, maintenance and chemoresistance of human cancer. 5 Although less common, genetic deletion or mutation of BCL-2 family proapoptotic proteins has also been implicated in tumorigenesis. In mice, Bax deletion potentiates SV40 T121-induced tumors of the choroid plexus, 6 C3(1)/SV40 large T antigen-induced mammary tumors 7 and Myc-induced pancreatic b-cell tumors. 8 Deletion of Bax and Bak cooperates with E1A and dominant-negative p53 to transform primary baby mouse kidney epithelial cells into highly invasive carcinomas, 9 and with mutant Kras G12D to generate sinonasal adenocarcinomas. 10 In humans, Bax loss-of-function mutations occur in 50% of mismatch mutation repair colon adenocarcinomas 11 and in 20% of cell lines derived from a broad spectrum of human hematopoietic malignancies. 12 Interestingly, expression of Baxc, a more potent inducer of apoptosis than Baxa, occurs within 25% of human glioblastomas and both retards tumor growth in xenograft models and correlates with longer patient survival. 13 Thus, as the essential gateway to mitochondrial apoptosis, BAX and BAK appear to directly impact the dynamics of murine and human tumorigenesis.
Given the clinical consequences of severe apoptotic blockade, most notably in oncogenesis, chemoresistance and cancer relapse, we sought to examine the impact of BAX/BAK deficiency in aged mice, overcoming the embryonic lethality of Bax/Bak deletion by use of conditional Bax deletion in a Bak À / À background. We focused in particular on examining the contribution of apoptosis suppression within the neural stem cell niche to adult-onset tumorigenesis. Whereas BAX and BAK are known to limit the size of the neural stem cell pool, 14 the link between a deactivated mitochondrial apoptosis gateway and the development of stem cell-driven cancer remain unknown. Here, we find that conditional deletion of Bax in the Nestin-positive cells of Bak À / À mice gives rise to progressive neural progenitor cell hyperplasia and frank brain tumors, in addition to a highly undifferentiated and aggressive neoplasm of the testis, a peripheral site of stem cell-associated Nestin expression.
RESULTS

Progressive megalencephaly in Nestin
Cre Bax fl/fl Bak À / À mice Although the majority of Bax À / À Bak À / À mice die in utero, rare survivors live long enough to develop accumulations of neural progenitor cells within the SVZ, hippocampus, cerebellum and olfactory bulb of the brain. 4, 14 To investigate the long-term consequences of this aberrant stem cell niche expansion, we bred mice with a germline deletion of Bak 4 to animals bearing a floxed (fl) conditional allele of Bax, 15 which was then deleted by Cre recombinase under control of the rat Nestin promoter to yield a central nervous system deficient in BAX and BAK. 16 Strikingly, Bax/Bak deletion produced an overall 34% increase in brain weight compared with wild-type mice ( Figure 1a) . A statistically significant gene dosage effect was observed with stepwise progression in severity of megalencephaly from In all, 20% of Nestin Cre Bax fl/fl Bak À / À brain tumors manifested aggressive, hypercellular and infiltrative features, with gross head deformity and notable midline shift (Figures 3a-d) . The tumors were comprised of dense cellular sheets of small, round-to spindle-shaped, blue cells with scant cytoplasm (Figures 3e-g ). Infiltrating cells were observed at the tumor edges, within the subarachnoid space, and at non-contiguous distal sites. Although small pseudorosettes were occasionally observed, the tumor cells predominantly grew in an angiocentric pattern with perivascular cuffing and associated satellitosis. Whereas the tumor cells were positive for NeuN and Sox2, and negative for glial fibrillary acidic protein, like the neural progenitor cells, a large subset also expressed Olig2 (Figures 3h-j and Supplementary Figure 9B) , a neural stem cell transcription factor that regulates fate specification of motor neurons and oligodendroglia, and is commonly expressed in human gliomas. 17, 18 In contrast to the benignappearing tumors (Figure 2h ), the aggressive masses demonstrated a correspondingly high Ki-67 proliferation index (Figure 3k) . Consistent with the neuronal deletion of Bax and Bak, the presence of apoptotic bodies was strikingly absent from the tumor tissue.
Testicular tumorigenesis in Nestin
Cre Bax fl/fl Bak À / À mice In surveying peripheral tissues that express Nestin, 19 we surprisingly identified high-grade testicular masses in 63% (12 of 19) of the Nestin Bak À / À mice displayed normal spermatogenesis (Figure 4d ). Although the highly undifferentiated appearance of the interstitial tumor cells was suggestive of an immune cell malignancy, the cells were negative for both CD3 and B220 (Supplementary Figure 11) .
To investigate the cell of origin for the testicular tumors, we generated Nestin
Cre ROSA LacZ mice and conducted a fate-mapping study that revealed selective LacZ staining of intertubular Leydig cells as well as occasional germ cells, but no labeling of control ROSA LacZ testis (Figures 4e and f) . Nestin expression within the testis has previously been localized to vascular progenitor cells, which transdifferentiate to produce Leydig cells, 21, 22 and within the germ cell lineage. Bak À / À testes, whereas only one signature was significantly enriched in wild-type testes (Figure 5b) . The embryonic stem cell signature can be subdivided into distinct subsignatures that include Myc-related factors (Myc module), core pluripotency factors (Core module) and Polycomb complex factors (PrC module), with the Myc module accounting for the predominant similarity of embryonic stem cells to cancer cells. 26 Interestingly, the tumor-bearing testes are enriched for both the Myc and Core modules, while the PrC module is repressed (Figure 5c 
DISCUSSION
The adult brain retains a pool of repopulating neural progenitor cells that reside in the perivascular niche of the SVZ and migrate along the rostral migratory stream to the olfactory bulb and to sites of injury. 28 The long-term self-renewal capacity of such cell populations within the brain represents a potential vulnerability for oncogenesis should the critical balance between progenitor cell life, death and differentiation become deregulated. Although loss of p53 alone within the SVZ is not sufficient for tumor formation, the proliferative advantage leads to hypercellularity, rapid differentiation and increased p53-independent apoptosis, 29 highlighting that p53 restrains the adult neural stem cell pool. 30 The combined loss of p53 with other neural stem cell regulators, such as PTEN, trigger frank neoplastic transformation. 31 Like loss of p53, combined Bax/Bak deletion revealed a key role for these multidomain proapoptotic members of the BCL-2 family in regulating the size of the neural stem cell pool. 4 However, unlike the capacity of p53 À / À cells to engage a p53-independent apoptotic pathway, Bax À / À Bak À / À cells sustain a profound block in apoptosis. 2 Whereas such a severe apoptotic defect in selfrenewing neural progenitor cells would be expected to predispose to brain tumorigenesis, the embryonic lethality of Bax À / À Bak À / À mice and foreshortened lifespan of the limited survivors precluded longitudinal analysis. To circumvent this limitation and examine the oncogenic impact of deleting Bax/Bak in a stem cell niche, we generated and characterized Nestin Cre Bax fl/fl Bak À / À mice as a model for progenitor cell-driven tumorigenesis.
We find that preventing Nestin-positive neural progenitor cell apoptosis through targeted Bax/Bak deletion gives rise to substantial and progressive hypercellularity both within and emerging from the SVZ. In a subset of mice, the progenitor cell hyperplasia and aberrant migratory activity give rise to frank subhippocampal tumors. Interestingly, the observed rosetting pattern of neurocytic growth is found in several human cancers, yet the emergence of this pattern in mice is strikingly rare. 32 For example, the constellation of neurocytic cells, abundant neoplastic neuropil and rosette pattern of growth is most similar to embryonic neurogenic tumors of childhood, such as cerebral neuroblastoma and embryonal tumor with abundant neuropil and true rosettes (ETANTR). 33, 34 Rosette-forming glioneuronal tumors of the ventricular system (RGNT) shares the features of tumor location and presence of rosettes. 35 Whereas the hyperplastic progenitor cells in non-tumor-bearing mice manifest NeuN and Sox2 immunoreactivity, the large tumors that take hold outside of the stem cell niche contain more differentiated neurons that lose Sox2 positivity, consistent with initiation of a mature neuronal differentiation program upon emigration from the stem cell niche. 36 The development of highly aggressive brain tumors in a smaller subset of Nestin Cre Bax fl/fl Bak À / À mice underscores the malignant potential of neural progenitors that lack an intact mitochondrial apoptotic pathway. These highly infiltrative tumors retain NeuN and Sox2 positivity, and also express Olig2, a 
ROSA
LacZ reporter mice (e), but not in ROSA LacZ control animals (f).
transcription factor that is highly expressed in brain cancer stem cells, required for neural progenitor cell proliferation, and a potent suppressor of p53 activity. 17, 18 In addition to brain tumorigenesis, 
Histology and immunohistochemistry
Mouse tissues were fixed in either Bouin's or 10% formalin for 424 h, passed through graded alcohols and embedded in paraffin. Slides containing 5-mm-thick sections were used for H&E staining or immunohistochemistry. Slides were soaked in xylene, passed through graded alcohols and immersed in distilled water. Immunohistochemistry was performed using the following conditions: (1) pressure cooker antigen retrieval (0.01 M citrate buffer, pH 6.0), followed by antibodies to glial fibrillary acidic protein (1:20 000; Z0334; DAKO, Glostrup, Denmark), Olig2 (1:500; AB9610; Millipore, Billerica, MA, USA), Sox2 (1:100; 3579; Cell Signaling, Danvers, MA, USA), NeuN (1:7500; MAB377; Millipore) and microtubule-associated protein 2 (1:5000; M4403; Sigma-Aldrich, St Louis, MO, USA); (2) pressure cooker antigen retrieval (EDTA buffer, pH 8.0), followed by Ki-67 immunostaining (1:250; VP-RM04; Vector Laboratories, Burlingame, CA, USA); (3) antisynaptophysin immunostaining (1:100; 180130; Life Technologies, Grand Island, NY, USA) without antigen retrieval; or (4) 10-min proteinase K-based antigen retrieval, followed by anti-EGFR immunostaining (1:400; M3563; DAKO). For antibodies generated in mice, a mouse-on-mouse IgG blocking kit (BMK-2202; Vector Laboratories) was employed according to the manufacturer's instructions. Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining was performed according to the manufacturer's protocol (S7100, Apoptag, Millipore).
LacZ staining
Mouse tissues were removed and fixed in 4% paraformaledhyde/ phosphate-buffered saline, rinsed with Buffer A (100 mM sodium phosphate, 2 mM MgCl 2 , 0.01% sodium deoxycholate and 0.02% NP-40), and stained with 5 mM potassium ferricyanide, 5 mM potassium ferrocyonide and 1 mg/ml X-gal in Buffer A. Tissues were then post-fixed in 10% formalin, embedded in paraffin and counterstained with neutral fast red.
Microarray analysis
Brains were cut mid-sagitally and distinct regions removed under a dissection microscope. Testes were flash frozen and cut in half for histology and RNA extraction. Total RNA was extracted from tissues frozen in Trizol (Life Technologies) using Qiagen RNeasy (Qiagen, Valencia, CA, USA). RNA was reverse transcribed and hybridized to a mouse Gene 1.0 ST chip for the testes samples and to a mouse 430 2.0 full chip for the brain samples at the Dana-Farber Cancer Institute Microarray Core Facility. Array quality was assessed using R/Bioconductor. 37 All arrays passed visual inspection and no technical outliers were identified. Transcript level summarization and RMA normalization of CEL files was achieved using the Oligo package. 38 To identify genes correlating with the phenotypic groups, we used limma 39 to fit a statistical linear model to the data and then tested for differential gene expression in the contrasts of interest. Results were adjusted for multiple testing using the Benjamini and Hochberg method. 40 GSEA was performed with the pre-ranked implementation of the GSEA software package 41 using the moderated t-statistic from limma to determine rank order. Tissue-specific gene sets for the four different components of the testis were derived from the E-AFFX-5 data set available at ArrayExpress. Briefly, each of the four testis components was first analyzed individually using Barcode 24 to determine the subset of genes that are expressed in that tissue, and genes that were found to be expressed in all four tissues were excluded. Barcode analysis was similarly used in deriving gene signatures for an aggressive brain tumor and brains bearing SVZ proliferations, with the additional filtering criteria requiring an absolute fold-change greater than two relative to wild-type tissue. Stem cell signatures were identified from the GeneSigDB database 42 and were tested for significance using the CP (v.2.5) gene set from MSigDB as background.
